Literature DB >> 28503698

Breast reconstruction rate and profile in a Singapore patient population: a National University Hospital experience.

Nadia Sim1, Sharon Soh1, Chuan Han Ang2, Chor Hoong Hing1,3, Han Jing Lee3,4, Vigneswaran Nallathamby3,4, Yan Lin Yap4, Wei Chen Ong4, Thiam Chye Lim4, Jane Lim4.   

Abstract

INTRODUCTION: Breast reconstruction is an integral part of breast cancer management with the aim of restoring a breast to its natural form. There is increasing awareness among women that it is a safe procedure and its benefits extend beyond aesthetics. Our aim was to establish the rate of breast reconstruction and provide an overview of the patients who underwent breast reconstruction at National University Hospital (NUH), Singapore.
METHODS: We evaluated factors that impact a patient's decision to proceed with breast reconstruction, such as ethnicity, age, time and type of implant. We retrospectively reviewed the medical records of women who had breast cancer and underwent breast surgery at NUH between 2001 and 2010.
RESULTS: The breast reconstruction rate in this study was 24.3%. There were 241 patients who underwent breast reconstruction surgeries (including delayed and immediate procedures) among 993 patients for whom mastectomies were done for breast cancer. Chinese patients were the largest ethnic group who underwent breast reconstruction after mastectomy (74.3%). Within a single ethnic patient group, Malay women had the largest proportion of women undergoing breast reconstruction (60.0%). The youngest woman in whom cancer was detected in our study was aged 20 years. Malay women showed the greatest preference for autologous tissue breast reconstruction (92.3%). The median age at cancer diagnosis of our cohort was 46 years.
CONCLUSION: We noted increases in the age of patients undergoing breast reconstruction and the proportion of breast reconstruction cases over the ten-year study period. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  breast; breast reconstruction; mammoplasty; reconstruction

Mesh:

Year:  2017        PMID: 28503698      PMCID: PMC6024220          DOI: 10.11622/smedj.2017035

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  24 in total

Review 1.  Breast reconstruction after mastectomy for breast cancer.

Authors:  Jennica Platt; Nancy Baxter; Toni Zhong
Journal:  CMAJ       Date:  2011-11-07       Impact factor: 8.262

2.  Use of breast reconstruction after mastectomy following the Women's Health and Cancer Rights Act.

Authors:  Amy K Alderman; Yongliang Wei; John D Birkmeyer
Journal:  JAMA       Date:  2006-01-25       Impact factor: 56.272

3.  Socioeconomic position and breast reconstruction in Danish women.

Authors:  Gitte B Hvilsom; Lisbet R Hölmich; Kirsten Frederiksen; Marianne Steding-Jessen; Søren Friis; Susanne O Dalton
Journal:  Acta Oncol       Date:  2010-11-22       Impact factor: 4.089

4.  Breast reconstruction in older women: advantages of autogenous tissue.

Authors:  Joan E Lipa; Adel A Youssef; Henry M Kuerer; Geoffrey L Robb; David W Chang
Journal:  Plast Reconstr Surg       Date:  2003-03       Impact factor: 4.730

Review 5.  Breast cancer amongst Filipino migrants: a review of the literature and ten-year institutional analysis.

Authors:  Jory S Simpson; Kaleigh Briggs; Ralph George
Journal:  J Immigr Minor Health       Date:  2015-06

6.  Disparities associated with breast reconstruction in Japan.

Authors:  Ayako Oda; Hiroyo Kuwabara; Kiyohide Fushimi
Journal:  Plast Reconstr Surg       Date:  2013-12       Impact factor: 4.730

Review 7.  Defining the role for autologous breast reconstruction after mastectomy: social and oncologic implications.

Authors:  Warren Matthew Rozen; Mark W Ashton; G Ian Taylor
Journal:  Clin Breast Cancer       Date:  2008-04       Impact factor: 3.225

8.  Inequalities in breast cancer reconstructive surgery according to social and locational status in Western Australia.

Authors:  S E Hall; C D J Holman
Journal:  Eur J Surg Oncol       Date:  2003-08       Impact factor: 4.424

9.  Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.

Authors:  Ke-Da Yu; Gen-Hong Di; Jiong Wu; Jin-Song Lu; Kun-Wei Shen; Zhen-Zhou Shen; Zhi-Min Shao
Journal:  Ann Surg Oncol       Date:  2007-06-13       Impact factor: 5.344

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

View more
  2 in total

1.  What are the appropriate thresholds for High Quality Performance Indicators for breast surgery in Australia and New Zealand?

Authors:  Shehnarz Salindera; Michelle Ogilvy; Andrew Spillane
Journal:  Breast       Date:  2020-01-30       Impact factor: 4.380

2.  Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals.

Authors:  Benlong Yang; Guosheng Ren; Erwei Song; Da Pan; Jing Zhang; Yongsheng Wang; Ning Liao; Jinhai Tang; Xiang Wang; Shude Cui; Feng Jin; Cuizhi Geng; Qiang Sun; Hongyuan Li; Zhimin Fan; Xuchen Cao; Haibo Wang; Shu Wang; Zhimin Shao; Jiong Wu
Journal:  Oncologist       Date:  2020-05-13       Impact factor: 5.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.